General Information of the Compound
| Compound ID |
CP0866113
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-3-(3-(2-((5-methyl-2-(methyloxy)-4-(4-(2-(methylsulfonyl)ethyl)-1-piperidinyl)phenyl)amino)-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C40H39F2N7O4S
|
||||||||||||||||||
| Molecular Weight |
751.86
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(N2CCC(CCS(C)(=O)=O)CC2)c(C)cc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C40H39F2N7O4S/c1-25-22-32(34(53-2)24-33(25)48-19-14-26(15-20-48)16-21-54(3,51)52)45-40-43-17-13-31(44-40)38-36(46-35-12-4-5-18-49(35)38)27-8-6-9-28(23-27)39(50)47-37-29(41)10-7-11-30(37)42/h4-13,17-18,22-24,26H,14-16,19-21H2,1-3H3,(H,47,50)(H,43,44,45)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CCYITMVYHGCYJS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor